These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 9303380

  • 21. Pharmacokinetic interaction of fluconazole and zidovudine in HIV-positive patients.
    Brockmeyer NH, Tillmann I, Mertins L, Barthel B, Goos M.
    Eur J Med Res; 1997 Sep 29; 2(9):377-83. PubMed ID: 9300934
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of combination therapy with delavirdine and zidovudine: a European/Australian phase II trial.
    Been-Tiktak AM, Boucher CA, Brun-Vezinet F, Joly V, Mulder JW, Jost J, Cooper DA, Moroni M, Gatell JM, Staszewski S, Colebunders R, Stewart GJ, Hawkins DA, Johnson MA, Parkin JM, Kennedy DH, Hoy JF, Borleffs JC.
    Int J Antimicrob Agents; 1999 Jan 29; 11(1):13-21. PubMed ID: 10075273
    [Abstract] [Full Text] [Related]

  • 23. Metabolism of delavirdine, a human immunodeficiency virus type-1 reverse transcriptase inhibitor, by microsomal cytochrome P450 in humans, rats, and other species: probable involvement of CYP2D6 and CYP3A.
    Voorman RL, Maio SM, Hauer MJ, Sanders PE, Payne NA, Ackland MJ.
    Drug Metab Dispos; 1998 Jul 29; 26(7):631-9. PubMed ID: 9660845
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetic interaction of amprenavir in combination with efavirenz or delavirdine in HIV-infected children.
    Wintergerst U, Engelhorn C, Kurowski M, Hoffmann F, Notheis G, Belohradsky BH.
    AIDS; 2000 Aug 18; 14(12):1866-8. PubMed ID: 10985332
    [No Abstract] [Full Text] [Related]

  • 25. Pharmacokinetic interaction between amprenavir and delavirdine after multiple-dose administration in healthy volunteers.
    Justesen US, Klitgaard NA, Brosen K, Pedersen C.
    Br J Clin Pharmacol; 2003 Jan 18; 55(1):100-6. PubMed ID: 12534646
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Interaction of delavirdine with human liver microsomal cytochrome P450: inhibition of CYP2C9, CYP2C19, and CYP2D6.
    Voorman RL, Payne NA, Wienkers LC, Hauer MJ, Sanders PE.
    Drug Metab Dispos; 2001 Jan 18; 29(1):41-7. PubMed ID: 11124228
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effect of delavirdine on plasma lipids and lipoproteins in patients receiving antiretroviral therapy.
    Roberts AD, Liappis AP, Chinn C, Parenti DM, Muesing RA, Schuck SZ, Hsia J, Simon GL.
    AIDS; 2002 Sep 06; 16(13):1829-30. PubMed ID: 12218397
    [Abstract] [Full Text] [Related]

  • 36. Multiple-Dose Pharmacokinetics of Delavirdine Mesylate and Didanosine in HIV-Infected Patients.
    Morse GD, Cohn SE, Shelton MJ, Greisberger C, Cox SR, Della-Coletta AA, Freimuth WW, Reichman RC.
    Clin Drug Investig; 2003 Sep 06; 23(5):323-8. PubMed ID: 17535044
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Clinical experience with adding delavirdine to combination therapy in patients in whom multiple antiretroviral treatment including protease inhibitors has failed.
    Bellman PC.
    AIDS; 1998 Jul 30; 12(11):1333-40. PubMed ID: 9708413
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.